No More Business as Usual: How Generative AI Is Real and Already Paying Off in RCM Guide
HIM insights from Cleveland Clinic and AKASA, distilled from a popular panel at HFMA Annual and the encore webinar
At HFMA’s Annual Conference, one of the most talked-about sessions featured Cleveland Clinic and AKASA unpacking how generative AI (GenAI) is already transforming the revenue cycle. Now, by popular demand, those insights have been turned into a practical guide for healthcare executives.
This playbook shares how Cleveland Clinic achieved measurable results — including a 40% improvement in coding accuracy — and offers actionable steps for other health systems looking to follow their lead.
In this guide, you’ll discover:
Why GenAI has moved from hype to real-world results in RCM
How to identify high-impact, measurable use cases
Proven strategies for staff engagement and adoption
What to look for in a GenAI partner
How to scale confidently using a crawl–walk–run model
Want to know what’s next for GenAI in healthcare? Fill out the form to start reading this guide from industry experts.
Get your free guide
"*" indicates required fields
Accuracy was our north star. The precision of results made it a compelling case to start. Within just a few weeks of partnering with AKASA, we saw a 40% improvement in coding accuracy — and that gave our teams the confidence to keep going.
Nick Judd, Senior Director, RCM and HIM, Cleveland Clinic
Bob Gross
Executive Director, Financial Decision Support and Analysis
Cleveland Clinic
Nick Judd, Senior Director, RCM and HIM
Cleveland Clinic
Benjamin Beadle-Ryby
SVP and Co-founder
AKASA
Want to see the full conversation? Watch the on-demand webinar right now.